BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bonekamp S, Shen J, Salibi N, Lai HC, Geschwind J, Kamel IR. Early response of hepatic malignancies to locoregional therapy-value of diffusion-weighted magnetic resonance imaging and proton magnetic resonance spectroscopy. J Comput Assist Tomogr. 2011;35:167-173. [PMID: 21412085 DOI: 10.1097/rct.0b013e3182004bfb] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Fayad LM, Jacobs MA, Wang X, Carrino JA, Bluemke DA. Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques. Radiology 2012;265:340-56. [PMID: 23093707 DOI: 10.1148/radiol.12111740] [Cited by in Crossref: 117] [Cited by in F6Publishing: 94] [Article Influence: 13.0] [Reference Citation Analysis]
2 Yang K, Zhang XM, Yang L, Xu H, Peng J. Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2016;22:4835-47. [PMID: 27239110 DOI: 10.3748/wjg.v22.i20.4835] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
3 Galbán CJ, Hoff BA, Chenevert TL, Ross BD. Diffusion MRI in early cancer therapeutic response assessment. NMR Biomed 2017;30. [PMID: 26773848 DOI: 10.1002/nbm.3458] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 7.0] [Reference Citation Analysis]
4 Afifi A, Naguib A, Seragaldin F. Diffusion weighted magnetic resonance imaging in assessment of hepatocellular carcinoma after chemoembolization. The Egyptian Journal of Radiology and Nuclear Medicine 2016;47:61-71. [DOI: 10.1016/j.ejrnm.2015.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhang LJ, Zhang Z, Xu J, Jin N, Luo S, Larson AC, Lu GM. Carbogen gas-challenge blood oxygen level-dependent magnetic resonance imaging in hepatocellular carcinoma: Initial results. Oncol Lett. 2015;10:2009-2014. [PMID: 26622788 DOI: 10.3892/ol.2015.3526] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
6 Sobhani F, Xu C, Murano E, Pan L, Rastegar N, Kamel IR. Hypo-Vascular Liver Metastases Treated with Transarterial chemoembolization: Assessment of Early Response by Volumetric Contrast-Enhanced and Diffusion-Weighted Magnetic Resonance Imaging. Transl Oncol 2016;9:287-94. [PMID: 27567951 DOI: 10.1016/j.tranon.2016.03.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
7 Zhang L, Zhao X, Ouyang H, Wang S, Zhou C. Diagnostic value of 3.0T (1)H MRS with choline-containing compounds ratio (∆CCC) in primary malignant hepatic tumors. Cancer Imaging 2016;16:25. [PMID: 27549094 DOI: 10.1186/s40644-016-0082-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]